BD Rhapsod Enhanced Cartridge Reagent KitV3 and 2 more items

The University of Virginia awarded contract A207_PO-0456432 to BD Biosciences Pharmingen on July 9, 2026, for the procurement of specialized molecular biology reagent kits. The contract, valued at $7,408.26, involves the delivery of three distinct product lines to Paul Woodman Wright at the University of Virginia. The award encompasses BD Rhapsody Enhanced Cartridge Reagent Kit V3, Rhapsody complementary deoxyribonucleic acid (cDNA) Kit, and Rhapsody Targeted messenger ribonucleic acid (mRNA) and Antibody Sequencing (AbSeq) Amplification Kit.

The line items specify a total of five units across the three product categories. BD Biosciences Pharmingen will deliver one unit of the BD Rhapsody Enhanced Cartridge Reagent Kit V3 at $2,677.86, two units of the Rhapsody cDNA Kit at $1,292.76 per unit, and two units of the Rhapsody Targeted mRNA & AbSeq Amp Kit at $1,072.44 per unit. These reagent kits are consumable supplies typically utilized in single-cell and spatial transcriptomics research applications. The cumulative contract value of $7,408.26 represents a single procurement action with no identified renewal or option periods in the provided documentation.